English

COLLATERAL THERAPEUTICS INC

EDGAR

Quarterly report (10-Q) · filed 2002-04-29

17 filing records in this dataset, filed from 1998-08-06 to 2002-04-29. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Insider filings have not been processed for this company yet.

See all insider transactions

Institutional holders (Form 13F) are not yet shown here.

Latest fiscal year

Revenue

6.39 million USD

1999 · USD

Exact inputs and evidence

Revenue: 6392212 USD Source

Operating margin

-139.4%

1999 · %

Exact inputs and evidence

Operating Income: -8910716 USD Source
Revenue: 6392212 USD Source

Operating cash flow

-6.36 million USD

1999 · USD

Exact inputs and evidence

Operating Cash Flow: -6359416 USD Source

Free cash flow

-6.88 million USD

1999 · USD

Exact inputs and evidence

Operating Cash Flow: -6359416 USD Source
Capital Expenditure: 520873 USD Source

Cash and cash equivalents: 15.7 million USD 2002-03-31 Source
Exact value

15667873 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-5.32 million USD

2001-04-01 – 2002-03-31

Exact inputs and evidence

Net income: -4523521 USD · 2001-04-01 – 2001-06-30 Source
Net income: -1035221 USD · 2001-07-01 – 2001-09-30 Source
Net income: -14569673 USD · 2001-01-01 – 2001-12-31 Source
Net income: -9203168 USD · 2001-01-01 – 2001-09-30 Source
Net income: 5600988 USD · 2002-01-01 – 2002-03-31 Source

Operating cash flow

-3.45 million USD

2001-04-01 – 2002-03-31

Exact inputs and evidence

Operating cash flow: -7606901 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: -3201931 USD · 2001-01-01 – 2001-03-31 Source
Operating cash flow: -8892417 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -7606901 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: -13134186 USD · 2001-01-01 – 2001-12-31 Source
Operating cash flow: -8892417 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: 6482777 USD · 2002-01-01 – 2002-03-31 Source

Capital expenditure

2.09 million USD

2001-04-01 – 2002-03-31

Exact inputs and evidence

Capital expenditure: 3135672 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 1454970 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 3338835 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 3135672 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 3478399 USD · 2001-01-01 – 2001-12-31 Source
Capital expenditure: 3338835 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 63111 USD · 2002-01-01 – 2002-03-31 Source

Free cash flow

-5.54 million USD

2001-04-01 – 2002-03-31

Exact inputs and evidence

Operating cash flow: -7606901 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: -3201931 USD · 2001-01-01 – 2001-03-31 Source
Operating cash flow: -8892417 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -7606901 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: -13134186 USD · 2001-01-01 – 2001-12-31 Source
Operating cash flow: -8892417 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: 6482777 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 3135672 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 1454970 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 3338835 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 3135672 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 3478399 USD · 2001-01-01 – 2001-12-31 Source
Capital expenditure: 3338835 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 63111 USD · 2002-01-01 – 2002-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2002-04-29.

Financial data available through: 2001-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 1999-12-31
Operating income: 5 of 11 periods available· newest 2001-12-31
Net income: 6 of 11 periods available· newest 2001-12-31
Operating cash flow: 6 of 11 periods available· newest 2001-12-31
Capital expenditure: 6 of 11 periods available· newest 2001-12-31
Total assets: 5 of 11 periods available· newest 2001-12-31
liabilities: No compatible figures in this window
Current assets: 5 of 11 periods available· newest 2001-12-31
Current liabilities: 5 of 11 periods available· newest 2001-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2001-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 34,194

Prior period

−USD 14.6 million

2000-01-01 – 2000-12-31
Current period

−USD 14.57 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-14569673 − -14603867 = 34194 USD

-14603867 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-14569673 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · COLLATERAL THERAPEUTICS INC · 2001-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Year-over-year change in Net income: 34194 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -14569673 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7219 Input fundies:NetIncome: -14603867 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7219
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 932,143

Prior period

−USD 12.2 million

2000-01-01 – 2000-12-31
Current period

−USD 13.13 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-13134186 − -12202043 = -932143 USD

-12202043 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-13134186 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · COLLATERAL THERAPEUTICS INC · 2001-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Year-over-year change in Operating cash flow: -932143 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -13134186 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7402 Input fundies:OperatingCashFlow: -12202043 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7402
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+418.1%

Prior period

USD 671,409

2000-01-01 – 2000-12-31
Current period

USD 3.48 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

3478399 − 671409 = 2806990 USD

671409 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
3478399 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · COLLATERAL THERAPEUTICS INC · 2001-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Year-over-year change in Capital expenditure: 2806990 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3478399 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7431 Input fundies:CapitalExpenditure: 671409 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7431
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1999 1999-01-01 – 1999-12-31

Revenue USD 6.39 million 100% of revenue
Operating costs Derived USD 15.3 million 239% of revenue
Operating income −USD 8.91 million −139% of revenue
Tax, interest and other Derived −USD 1.18 million −19% of revenue
Net income −USD 7.73 million −121% of revenue

Cash

Operating cash flow −USD 6.36 million −99% of revenue
Capital expenditure USD 520,873 8.1% of revenue
Free cash flow Derived −USD 6.88 million −108% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1997 Operating loss: operating costs were 123% of revenue.
1998 Operating loss: operating costs were 200% of revenue.
1999 Operating loss: operating costs were 239% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1997 1997-01-01 – 1997-12-31	5647189	6932614 Derived	-1285425	-166829 Derived	-1118596	-2896437 Derived	Source 1997-01-01 – 1997-12-31: 5647189 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -1285425 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -1118596 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -2550399 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 346038 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	5403481	10794567 Derived	-5391086	-486697 Derived	-4904389	-4306944 Derived	Source 1998-01-01 – 1998-12-31: 5403481 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -5391086 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -4904389 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -732120 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 3574824 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	6392212	15302928 Derived	-8910716	-1184911 Derived	-7725805	-6880289 Derived	Source 1999-01-01 – 1999-12-31: 6392212 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -8910716 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -7725805 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -6359416 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 520873 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 6.4M 1999

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-12-31	Revenue	5647189	Revenue: 5647189 Open source
19981998-12-31	Revenue	5403481	Revenue: 5403481 Open source
19991999-12-31	Revenue	6392212	Revenue: 6392212 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

18.3% 1999

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Year over year	No prior comparable period	Revenue: 5647189 Open source
19981998-12-31	Year over year	-4.3%	Revenue: 5403481 Open source Revenue: 5647189 Open source
19991999-12-31	Year over year	18.3%	Revenue: 6392212 Open source Revenue: 5403481 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -139.4% 1999

Net margin -120.9% 1999

Free cash flow margin -107.6% 1999

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Operating margin	-22.8%	Operating Income: -1285425 Open source Revenue: 5647189 Open source
19981998-12-31	Operating margin	-99.8%	Operating Income: -5391086 Open source Revenue: 5403481 Open source
19991999-12-31	Operating margin	-139.4%	Operating Income: -8910716 Open source Revenue: 6392212 Open source
19971997-12-31	Net margin	-19.8%	Net Income: -1118596 Open source Revenue: 5647189 Open source
19981998-12-31	Net margin	-90.8%	Net Income: -4904389 Open source Revenue: 5403481 Open source
19991999-12-31	Net margin	-120.9%	Net Income: -7725805 Open source Revenue: 6392212 Open source
19971997-12-31	Free cash flow margin	-51.3%	Revenue: 5647189 Open source Operating Cash Flow: -2550399 Open source Capital Expenditure: 346038 Open source
19981998-12-31	Free cash flow margin	-79.7%	Revenue: 5403481 Open source Operating Cash Flow: -732120 Open source Capital Expenditure: 3574824 Open source
19991999-12-31	Free cash flow margin	-107.6%	Revenue: 6392212 Open source Operating Cash Flow: -6359416 Open source Capital Expenditure: 520873 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -6.4M 1999

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-12-31	Operating cash flow	-2550399	Operating Cash Flow: -2550399 Open source
19981998-12-31	Operating cash flow	-732120	Operating Cash Flow: -732120 Open source
19991999-12-31	Operating cash flow	-6359416	Operating Cash Flow: -6359416 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -6.9M 1999

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-12-31	Free cash flow	-2896437	Operating Cash Flow: -2550399 Open source Capital Expenditure: 346038 Open source
19981998-12-31	Free cash flow	-4306944	Operating Cash Flow: -732120 Open source Capital Expenditure: 3574824 Open source
19991999-12-31	Free cash flow	-6880289	Operating Cash Flow: -6359416 Open source Capital Expenditure: 520873 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1997-12-31	Liabilities / assets	Not reported	Total Assets: 8069759 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 19266737 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 43415618 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

14.69× 1999

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Current assets / current liabilities	10.36×	Current Assets: 7776312 Open source Current Liabilities: 750502 Open source
19981998-12-31	Current assets / current liabilities	5.94×	Current Assets: 15781010 Open source Current Liabilities: 2657575 Open source
19991999-12-31	Current assets / current liabilities	14.69×	Current Assets: 40277805 Open source Current Liabilities: 2741735 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1996 1996-01-01 – 1996-12-31	−USD 390,008 Exact value Exact value: -390008 USD 1996-01-01 – 1996-12-31: -390008 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLATERAL THERAPEUTICS INC · 1996-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Net Income: -390008 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -390008 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0001047469-99-012588.txt#3688 The citation records this snapshot. The page link may show a newer release later.	−USD 106,635 Exact value Exact value: -106635 USD 1996-01-01 – 1996-12-31: -106635 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLATERAL THERAPEUTICS INC · 1996-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Operating Cash Flow: -106635 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -106635 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0001047469-99-012588.txt#3701 The citation records this snapshot. The page link may show a newer release later.	USD 96,504 Exact value Exact value: 96504 USD 1996-01-01 – 1996-12-31: 96504 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLATERAL THERAPEUTICS INC · 1996-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Capital Expenditure: 96504 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 96504 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0001047469-99-012588.txt#3704 The citation records this snapshot. The page link may show a newer release later.	−USD 203,139 Calculation and evidence -106635 − 96504 USD Exact free cash flow: -203139 USD 1996-01-01 – 1996-12-31: -106635 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 96504 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLATERAL THERAPEUTICS INC · 1996-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Free cash flow: -203139 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -106635 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0001047469-99-012588.txt#3701 Input fundies:CapitalExpenditure: 96504 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0001047469-99-012588.txt#3704 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 1.12 million Exact value Exact value: -1118596 USD 1997-01-01 – 1997-12-31: -1118596 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLATERAL THERAPEUTICS INC · 1997-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Net Income: -1118596 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1118596 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-00-013745.txt#3549 The citation records this snapshot. The page link may show a newer release later.	−USD 2.55 million Exact value Exact value: -2550399 USD 1997-01-01 – 1997-12-31: -2550399 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLATERAL THERAPEUTICS INC · 1997-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Operating Cash Flow: -2550399 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2550399 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-00-013745.txt#3562 The citation records this snapshot. The page link may show a newer release later.	USD 346,038 Exact value Exact value: 346038 USD 1997-01-01 – 1997-12-31: 346038 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLATERAL THERAPEUTICS INC · 1997-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Capital Expenditure: 346038 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 346038 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-00-013745.txt#3565 The citation records this snapshot. The page link may show a newer release later.	−USD 2.9 million Calculation and evidence -2550399 − 346038 USD Exact free cash flow: -2896437 USD 1997-01-01 – 1997-12-31: -2550399 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 346038 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLATERAL THERAPEUTICS INC · 1997-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Free cash flow: -2896437 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2550399 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-00-013745.txt#3562 Input fundies:CapitalExpenditure: 346038 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-00-013745.txt#3565 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 4.9 million Exact value Exact value: -4904389 USD 1998-01-01 – 1998-12-31: -4904389 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLATERAL THERAPEUTICS INC · 1998-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Net Income: -4904389 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4904389 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-01-008743.txt#3513 The citation records this snapshot. The page link may show a newer release later.	−USD 732,120 Exact value Exact value: -732120 USD 1998-01-01 – 1998-12-31: -732120 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLATERAL THERAPEUTICS INC · 1998-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Operating Cash Flow: -732120 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -732120 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-01-008743.txt#3527 The citation records this snapshot. The page link may show a newer release later.	USD 3.57 million Exact value Exact value: 3574824 USD 1998-01-01 – 1998-12-31: 3574824 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLATERAL THERAPEUTICS INC · 1998-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Capital Expenditure: 3574824 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3574824 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-01-008743.txt#3530 The citation records this snapshot. The page link may show a newer release later.	−USD 4.31 million Calculation and evidence -732120 − 3574824 USD Exact free cash flow: -4306944 USD 1998-01-01 – 1998-12-31: -732120 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 3574824 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLATERAL THERAPEUTICS INC · 1998-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Free cash flow: -4306944 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -732120 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-01-008743.txt#3527 Input fundies:CapitalExpenditure: 3574824 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-01-008743.txt#3530 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 7.73 million Exact value Exact value: -7725805 USD 1999-01-01 – 1999-12-31: -7725805 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLATERAL THERAPEUTICS INC · 1999-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Net Income: -7725805 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7725805 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7219 The citation records this snapshot. The page link may show a newer release later.	−USD 6.36 million Exact value Exact value: -6359416 USD 1999-01-01 – 1999-12-31: -6359416 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLATERAL THERAPEUTICS INC · 1999-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Operating Cash Flow: -6359416 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6359416 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7402 The citation records this snapshot. The page link may show a newer release later.	USD 520,873 Exact value Exact value: 520873 USD 1999-01-01 – 1999-12-31: 520873 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLATERAL THERAPEUTICS INC · 1999-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Capital Expenditure: 520873 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 520873 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7431 The citation records this snapshot. The page link may show a newer release later.	−USD 6.88 million Calculation and evidence -6359416 − 520873 USD Exact free cash flow: -6880289 USD 1999-01-01 – 1999-12-31: -6359416 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 520873 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLATERAL THERAPEUTICS INC · 1999-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Free cash flow: -6880289 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6359416 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7402 Input fundies:CapitalExpenditure: 520873 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7431 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 14.6 million Exact value Exact value: -14603867 USD 2000-01-01 – 2000-12-31: -14603867 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLATERAL THERAPEUTICS INC · 2000-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Net Income: -14603867 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14603867 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7219 The citation records this snapshot. The page link may show a newer release later.	−USD 12.2 million Exact value Exact value: -12202043 USD 2000-01-01 – 2000-12-31: -12202043 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLATERAL THERAPEUTICS INC · 2000-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Operating Cash Flow: -12202043 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12202043 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7402 The citation records this snapshot. The page link may show a newer release later.	USD 671,409 Exact value Exact value: 671409 USD 2000-01-01 – 2000-12-31: 671409 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLATERAL THERAPEUTICS INC · 2000-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Capital Expenditure: 671409 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 671409 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7431 The citation records this snapshot. The page link may show a newer release later.	−USD 12.87 million Calculation and evidence -12202043 − 671409 USD Exact free cash flow: -12873452 USD 2000-01-01 – 2000-12-31: -12202043 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 671409 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLATERAL THERAPEUTICS INC · 2000-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Free cash flow: -12873452 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12202043 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7402 Input fundies:CapitalExpenditure: 671409 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7431 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 14.57 million Exact value Exact value: -14569673 USD 2001-01-01 – 2001-12-31: -14569673 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLATERAL THERAPEUTICS INC · 2001-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Net Income: -14569673 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14569673 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7219 The citation records this snapshot. The page link may show a newer release later.	−USD 13.13 million Exact value Exact value: -13134186 USD 2001-01-01 – 2001-12-31: -13134186 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLATERAL THERAPEUTICS INC · 2001-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Operating Cash Flow: -13134186 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13134186 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7402 The citation records this snapshot. The page link may show a newer release later.	USD 3.48 million Exact value Exact value: 3478399 USD 2001-01-01 – 2001-12-31: 3478399 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLATERAL THERAPEUTICS INC · 2001-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Capital Expenditure: 3478399 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3478399 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7431 The citation records this snapshot. The page link may show a newer release later.	−USD 16.61 million Calculation and evidence -13134186 − 3478399 USD Exact free cash flow: -16612585 USD 2001-01-01 – 2001-12-31: -13134186 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 3478399 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLATERAL THERAPEUTICS INC · 2001-12-31 COLLATERAL THERAPEUTICS INC (edgar:1060329) Free cash flow: -16612585 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-12T13:33:14Z Snapshot: d5cccb179978442b782622bfa1b5fd80e25fc0b9f8e870c1a98523f863da98b9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060329?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13134186 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7402 Input fundies:CapitalExpenditure: 3478399 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060329/0000912057-02-012627.txt#7431 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

17 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-12. Source filing dates and reporting periods are shown separately.

Identifiers: 0001060329, 1060329, edgar:1060329

COLLATERAL THERAPEUTICS INC

Holdings and insider activity

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1999 1999-01-01 – 1999-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation